Mind Medicine Inc (MNMD) Peer Comparison
$15.75
$0.37
(2.41%)
As on 13-Feb-2026 09:30EDT
Market cap
$1,460 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
12.9
Div. Yield
0 %
Edit
| Mind Medicine Inc (MNMD) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
Market cap ($ Mln) |
1,460 | 714 | 413 | 109 |
Revenue ($ Mln) |
-- | -- | -- | -- |
Net Profit ($ Mln) |
-168.10 | -24.75 | -131.58 | -38.21 |
Net Margin (%) |
-- | -- | -- | -- |
RoE (%) |
-95.13 | -12.45 | -61.82 | -- |
Price to Earnings |
-- | -- | -- | -- |
Price-To-Book |
12.91 | 3.29 | 1.03 | 1,055.04 |
Cashflow ($ Mln)
| Mind Medicine Inc (MNMD) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Cash From Operating Activities
|
-79.13 | -1.85 | -68.91 | -19.88 |
|
Cash Flow from Investing Activities
|
-- | -- | 6.92 | -0.17 |
|
Cash from Financing Activities
|
253.20 | 0.81 | 254.51 | 5.03 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- |
Ratios
Profitability Ratios
| Mind Medicine Inc (MNMD) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
ROCE (%)
|
-61.13 | -45.46 | -42.39 | -130.13 |
|
ROE (%)
|
-95.13 | -46.18 | -61.82 | -135.90 |
|
ROA (%)
|
-51.30 | -43.16 | -45.92 | -77.26 |
|
EBIT Margin (%)
|
-- | -- | -- | -- |
|
Net Margin (%)
|
-- | -- | -- | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- |
Growth Ratios
| Mind Medicine Inc (MNMD) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | -- | -- | -- |
|
EBIT Growth (%)
|
-10.46 | -- | 60.38 | -- |
|
Net Profit Growth (%)
|
-71.88 | 61.99 | -26.64 | -8.96 |
|
EPS Growth (%)
|
0.76 | 0.69 | -29.75 | 0.00 |
|
Book Value Growth (%)
|
-53.47 | -- | -54.29 | -- |
Valuation Ratios
| Mind Medicine Inc (MNMD) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Price / Earnings
|
-5.38 | -1.94 | -0.67 | -3.21 |
|
Price / Book Value
|
2.42 | 0.98 | 0.18 | 12.22 |
|
Dividend Yield (%)
|
-- | -- | -- | -- |
|
EV/EBITDA
|
-3.14 | 0.06 | 1.99 | -2.29 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- |
Solvency Ratios
| Mind Medicine Inc (MNMD) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Debt to Equity
|
0.31 | 0.02 | 0.00 | 0.18 |
|
Short term debt to equity ratio
|
0.00 | 0.01 | 0.00 | 0.05 |
|
Current Ratio
|
3.30 | 11.32 | 13.78 | 2.82 |
|
Quick Ratio
|
3.30 | 24.39 | 13.78 | -- |
|
Interest Coverage
|
-33.52 | -373.28 | -- | -- |
Operating Efficiency Ratios
| Mind Medicine Inc (MNMD) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | -- | -- | -- |
|
Asset Turnover
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Receivable days
|
-- | -- | -- | -- |
|
Inventory Days
|
-- | -186.44 | -1,380.46 | -- |
|
Payable days
|
2,129.82 | 3,601.31 | 6,662.37 | 4,553.03 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
